Integra Lifesciences Holdings (IART) Deferred Taxes (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Deferred Taxes data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Deferred Taxes rose 172.38% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$63.1 million (down 220.22% YoY), and the FY2025 full-year result was -$66.3 million, down 219.64% from the prior year.
• Deferred Taxes improved to $1.3 million in Q1 2026, from -$10.9 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $4.0 million in Q2 2022 to a low of -$44.8 million in Q2 2025.
• A 5-year average of -$6.0 million and a median of -$2.9 million in 2024 frame the typical range for Deferred Taxes.
• Across the five-year window, Deferred Taxes soared 387.2% in 2022 and sank 2331.18% in 2025, its largest moves.
• Tracing IART's Deferred Taxes over 5 years: stood at -$6.0 million in 2022, then slumped by 146.48% to -$14.8 million in 2023, then soared by 52.94% to -$7.0 million in 2024, then slumped by 56.67% to -$10.9 million in 2025, then surged by 112.11% to $1.3 million in 2026.
• Business Quant data shows IART's Deferred Taxes at $1.3 million in Q1 2026, -$10.9 million in Q4 2025, and -$8.7 million in Q3 2025.